Skip to main content
. 2018 Apr 19;41(7):1406–1413. doi: 10.2337/dc17-2419

Table 1.

Demographics and CGM measures

CF HC P
n 93 29
Age (years) 14 ± 3 14 ± 4 0.99
Male 44 (47) 12 (41) 0.58
BMI z score −0.09 ± 0.8 −0.29 ± 0.7 0.21
Weight (kg) 49.4 ± 13.3 46.2 ± 14.7 0.31
Height (cm) 157.8 ± 13.3 155.0 ± 16.1 0.39
Race 0.20
 White 83 (89) 25 (86)
 Hispanic 9 (10) 2 (7)
 Other 1 (1) 2 (7)
Genotype
 Classes I–III 84 (90)
 Classes IV and V 4 (4)
 Unidentified 5 (6)
Pancreatic insufficient 90 (97)
Gastronomy tube feedings 18 (19)
CFTR modulator use 28 (30)
Insulin use 23 (25)
FVC (%) 98 ± 14
FEV1 (%) 90 ± 13
Fasting plasma glucose (mg/dL) 97 ± 22 88 ± 8 <0.0007
1-h plasma glucose (mg/dL) 201 ± 61 112 ± 26 (n = 12) <0.0001
2-h plasma glucose (mg/dL) 150 ± 50 107 ± 22 <0.0001
CF and normal glycemia 24 (26)
CF and abnormal glycemia 41 (44)
CF-related diabetes 28 (30)
HbA1c [% (mmol/mol)] 5.7 ± 0.8 (39 ± 9) 5.1 ± 0.2 (32 ± 2) <0.0001
FA (mmol/L) 243 ± 34 234 ± 16 0.06
Total albumin (g/dL) 4.2 ± 0.4 4.4 ± 0.3 0.03
GA (%) 13.0 ± 2.7 12.1 ± 0.9 0.01
1,5-AG (μg/mL) 18.9 ± 7.4 23.7 ± 8.2 0.008
CGM measures
 Average glucose (mg/dL) 116 ± 29 101 ± 10 <0.0001
 Average day glucose (mg/dL) 118 ± 31 101 ± 10 <0.0001
 Average night glucose (mg/dL) 112 ± 27 99 ± 9 0.0001
 Maximum day glucose (mg/dL) 217 ± 59 148 ± 23 <0.0001
 Maximum night glucose (mg/dL) 170 ± 52 135 ± 23 <0.0001
 Minimum glucose (mg/dL) 63 ± 13 66 ± 10 0.21
 Average AUC/day (mg/min/dL) 1.7 × 105 ± 4.2 × 104 1.4 × 105 ± 1.4 × 104 <0.0001
 Excursions >140/day 2.8 ± 1.5 0.8 ± 1 <0.0001
 Excursions >200/day 0.5 ± 0.7 0 ± 0 <0.0001
 % time >140 mg/dL 14 ± 17 1.9 ± 4.6 <0.0001
 % time >200 mg/dL 3 ± 13 0 ± 0 0.03
 % time <70 mg/dL 2 ± 4 1.6 ± 2.4 0.18
 % time <60 mg/dL 1 ± 3 0.2 ± 0.5 0.01
 SD (mg/dL) 25 ± 13 13 ± 3 <0.0001
 CV 0.2 ± 0.06 0.1 ± 0.03 <0.0001
 MAGE (mg/dL) 58 ± 28 27 ± 8 <0.0001

Data are mean ± SD or n (%) unless otherwise indicated. FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.